6.60
-0.65
(-8.97%)
As of 8:09:47 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in TWD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 14 |
| Avg. Estimate | 143.62B | 153.83B | 665.61B | 751.89B |
| Low Estimate | 140.63B | 147.41B | 632.87B | 649.61B |
| High Estimate | 147.6B | 165.03B | 710.88B | 839.88B |
| Year Ago Sales | 132.8B | 140.24B | 595.41B | 665.61B |
| Sales Growth (year/est) | 8.15% | 9.69% | 11.79% | 12.96% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2DQ.F | -- | -- | -- | -- |
| S&P 500 | 6.55% | 6.50% | 9.70% | 14.29% |
Upgrades & Downgrades
| Upgrade | UBS: Neutral to Buy | 10/15/2024 |
| Upgrade | Goldman Sachs: Neutral to Buy | 7/28/2023 |
| Downgrade | HSBC: Hold to Reduce | 6/28/2023 |
| Downgrade | Goldman Sachs: Buy to Neutral | 10/7/2021 |
| Initiated | Goldman Sachs: Buy | 9/4/2019 |
| Upgrade | UBS: Neutral to Buy | 5/31/2016 |